BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 29916054)

  • 1. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
    Scheiner B; Stammet PR; Pokorny S; Bucsics T; Schwabl P; Brichta A; Thaler J; Lampichler K; Ba-Ssalamah A; Ay C; Ferlitsch A; Trauner M; Mandorfer M; Reiberger T
    Wien Klin Wochenschr; 2018 Jul; 130(13-14):446-455. PubMed ID: 29916054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
    Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
    Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L; Pastori D; Farcomeni A; Violi F
    Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation therapy early is safe in portal vein thrombosis patients with acute variceal bleeding: a multi-centric randomized controlled trial.
    Gao Z; Li S; Zhao J; Li J; Gao Y
    Intern Emerg Med; 2023 Mar; 18(2):513-521. PubMed ID: 36692588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
    Naymagon L; Tremblay D; Zubizarreta N; Moshier E; Mascarenhas J; Schiano T
    Dig Dis Sci; 2021 Oct; 66(10):3619-3629. PubMed ID: 33151401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis.
    Chen H; Liu L; Qi X; He C; Wu F; Fan D; Han G
    Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):82-9. PubMed ID: 26513611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience.
    Florescu MM; Costache A; Iacob SM; Pietrareanu C; Ester C; Cerban R; Dumitru R; Grasu M; Lupescu I; Gheorghe L
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):374-379. PubMed ID: 34551038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
    Delgado MG; Seijo S; Yepes I; Achécar L; Catalina MV; García-Criado A; Abraldes JG; de la Peña J; Bañares R; Albillos A; Bosch J; García-Pagán JC
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):776-83. PubMed ID: 22289875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.
    Koh JH; Liew ZH; Ng GK; Liu HT; Tam YC; De Gottardi A; Wong YJ
    Dig Liver Dis; 2022 Jan; 54(1):56-62. PubMed ID: 34393072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.
    Zampino R; Lebano R; Coppola N; Macera M; Grandone A; Rinaldi L; De Sio I; Tufano A; Stornaiuolo G; Adinolfi LE; Durante-Mangoni E; Battista GG; Niglio A
    Saudi J Gastroenterol; 2018; 24(1):25-29. PubMed ID: 29451181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
    Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis.
    Zhang Z; Zhao Y; Han B; Zhu Z; Sun L; Cui X
    Clin Appl Thromb Hemost; 2022; 28():10760296221104797. PubMed ID: 35656719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis.
    Chun HS; Choe AR; Lee M; Cho Y; Kim HY; Yoo K; Kim TH
    Clin Mol Hepatol; 2021 Oct; 27(4):535-552. PubMed ID: 34130370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Menchise A; Martino R; Scaglione M; Giovine S; Romano L; Balzano A
    J Clin Gastroenterol; 2010 Jul; 44(6):448-51. PubMed ID: 19730112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.